Patents by Inventor Gerald Preibisch

Gerald Preibisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of leptin antagonists for treating insulin resistance in type II diabetes
    Patent number: 6399745
    Abstract: The invention relates to pharmaceutical agents containing leptin antagonists for treating Type II diabetes. One leptin antagonist is based on a murine leptin fragment and comprises amino acids 116 to 167 or 116 to 166. Methods of treating Type II diabetes are also disclosed.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: June 4, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Johann Ertl, Gerald Preibisch, Günter Müller